Your session is about to expire
← Back to Search
Pre-Surgery Hypofractionated Radiation Therapy for Soft Tissue Sarcoma
Study Summary
This trial looks at a shorter, higher-dose radiation therapy to see if it decreases wound complications from surgery for patients with localized soft tissue sarcomas.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Side effects data
From 2023 Phase 3 trial • 107 Patients • NCT03324802Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- You are expected to live for at least 6 more months.I am of childbearing age and not using birth control.My cancer is one of the following types: rhabdomyosarcoma, soft tissue osteosarcoma, soft tissue Ewing sarcoma, or it is benign.I've had radiation therapy before on the same area where my sarcoma is now.My scans show no cancer spread to lymph nodes or distant parts of the body.I am capable of limited self-care and spend less than half of my day in bed or sitting.My cancer has spread to lymph nodes or other parts of my body.I have a confirmed soft tissue sarcoma in my limbs or trunk and am eligible for surgery to remove it.I am currently breastfeeding.You are pregnant.
- Group 1: Treatment (hypofractionated radiation therapy, resection)
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
Are there any vacancies still available to join this trial?
"Clinicaltrials.gov confirms that the trial is still in need of participants; it was first published on November 30th 2020 and has been updated most recently on May 3rd 2022."
Does Hypofractionated Radiation Therapy pose any risks to patients?
"There is preliminary evidence that Hypofractionated Radiation Therapy is safe, so it earned a rating of 2."
What is the aggregate sum of individuals participating in this clinical examination?
"Affirmative. Credentialed on clinicaltrials.gov is the information that this medical trial, first posted November 30th 2020, is still searching for participants. A total of 120 individuals need to be enrolled from a single health facility."
Share this study with friends
Copy Link
Messenger